Open Access · CC BY 4.0
Biosimilars: state of the art in the treatment of rheumatic diseases
Exploration of Musculoskeletal Diseases · 2026
DOI: 10.37349/emd.2026.1007115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration of Musculoskeletal Diseases, 2026. Verfasst von Valderilio Feijó Azevedo. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Azevedo, V. F. (2026). Biosimilars: state of the art in the treatment of rheumatic diseases. Exploration of Musculoskeletal Diseases. https://doi.org/10.37349/emd.2026.1007115
Vancouver
Azevedo VF. Biosimilars: state of the art in the treatment of rheumatic diseases. Exploration of Musculoskeletal Diseases. 2026. doi:10.37349/emd.2026.1007115
BibTeX
@article{Azevedo2026,
author = {Azevedo, Valderilio Feijó},
title = {Biosimilars: state of the art in the treatment of rheumatic diseases},
journal = {Exploration of Musculoskeletal Diseases},
year = {2026},
doi = {10.37349/emd.2026.1007115}
}
EUVIMED